CompletedNCT00341627
Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families
Studying Chordoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Mary L McMaster, M.D., M.DNational Cancer Institute (NCI)
- Enrollment
- 56 enrolled
- Eligibility
- 110 years · All sexes
- Timeline
- 1999 – 2020
Study locations (2)
- University of Iowa, Iowa City, Iowa, United States
- NCI, DCEG, Clinical Genetics Branch, Rockville, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00341627 on ClinicalTrials.govOther trials for Chordoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06957327A Study of ERAS-601 in People With ChordomaMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGPHASE2NCT06787664A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic ChordomaSichuan Baili Pharmaceutical Co., Ltd.
- RECRUITINGPHASE2NCT06794645Pembrolizumab and Pemetrexed for Progressive ChordomaSaint John's Cancer Institute
- RECRUITINGNCT06463262Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral ChordomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- RECRUITINGNANCT06029218Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton TherapyCentre Antoine Lacassagne
- ACTIVE NOT RECRUITINGPHASE2NCT05041127Cetuximab for the Treatment of Advanced Unresectable or Metastatic ChordomaM.D. Anderson Cancer Center
- RECRUITINGNCT05888064Multi-parametric Imaging in Personalized RadiotherapyCNAO National Center of Oncological Hadrontherapy
- RECRUITINGNCT04832620Image Assisted Optimization of Proton Radiation Therapy in Chordomas and ChondrosarcomasLeiden University Medical Center